First of all these are all ridiculous statements, the company that owned all this IP raised hundreds of millions for their cardio product this was their second thought product, so when you burn through hundreds of millions I'd find it pretty hard to commercialize anything when their flagship product is still churning hige cash and what they raised all the money for, do your homework people, it's like saying Lilly who wanted ora-lyn had the license for ot who wanted type two but Generex old management wanted type 1 sobtheu bought the license back and hundreds of millions went into type one with no result, so spare me the bull, especially bull that comes from a fired employee, looks like you guys should have a lot of questions for tony dolici on the next conference call, but for sure this clown who I know well is nothing but a clown.